A clearer route
to market.
Understand where your offer fits, which channels matter and what needs to happen before launch.
MARKET PRIORITIES + LAUNCH DIRECTIONWe connect promising consumer health ideas with the partners, markets and commercial direction they need to move forward.

NUVELO HEALTH is an independent consumer health business development and advisory partner, led by Lukasz Czepiel.
We bring a commercial lens to health innovation: connecting brand owners, manufacturers and distribution partners around a shared opportunity. Our work sits where product potential, local market needs and practical execution meet.
From Poland and CEE to Europe–Asia opportunities, we help turn an ambitious conversation into a focused next step.
A direct conversation with LukaszScience gives an idea potential.
Partnership gives it somewhere to go.
Less uncertainty between a promising opportunity and a practical way to pursue it.
Understand where your offer fits, which channels matter and what needs to happen before launch.
MARKET PRIORITIES + LAUNCH DIRECTIONFrame the right partner profile and evaluate commercial alignment, capabilities and responsibilities.
PARTNER CRITERIA + QUALIFIED DISCUSSIONSConnect strategy to decisions, ownership and milestones, with a scope shaped around your opportunity.
DEFINED ACTIONS + SHARED ACCOUNTABILITYThe ambition is simple: more days lived with vitality, independence and connection.
We see an opportunity to bring thoughtful health and wellbeing innovation into everyday life. That means asking better questions: Is there relevant evidence? Is the product useful? Can it reach the people it is designed for?
Our role is to connect that ambition with commercial reality — through product selection, market development and partnerships grounded in responsible communication.
How we build confidenceChoose the opportunity closest to yours. Explore the focus, the work and what a useful first step could look like.
Build a route into Poland and selected CEE markets, shaped around your product, category and commercial readiness.
Explore distribution developmentStart with a market-fit and route-to-market discussion.
Geography is a starting point. The right opportunity depends on category, partner capability and local requirements.
Assess product positioning, target channels and the profile of a suitable distribution partner. Build the commercial case before committing to a launch.
Discuss PolandWe build the relationship around clear expectations, relevant evidence and decisions both sides can stand behind.
Review the product rationale and supporting materials. Bring qualified scientific and regulatory specialists into the discussion when needed.
Agree the scope, responsibilities, milestones and commercial terms before execution. Surface assumptions and potential conflicts early.
Evaluate each market on its own merits. Product classification, claims, channel economics and partner requirements vary by country.
A named contact and direct dialogue. Start with Lukasz, then define the specialist support your project needs.
Every engagement is scoped individually. This is the structure we use to shape a productive collaboration.
Your product, ambition, evidence and current stage.
The opportunity, target market and key questions.
The right partner profiles and specialist input.
An agreed scope, owners and commercial milestones.
Tell us where you are headed. We will help frame a useful starting point.
A focused introduction.Brand owners, consumer health innovators, manufacturers and distribution partners exploring a new market, portfolio opportunity or commercial relationship.
Our starting point is distribution development: assessing market fit, defining partner criteria and shaping commercial discussions. The operating model, legal responsibilities and any required licensed activities are agreed for each project.
Projects can explore manufacturing, sourcing, licensing or market-entry relationships in either direction. Geography, partner availability, quality documentation and commercial feasibility are evaluated before commitments are made.
We start with the evidence supplied for the specific product and intended use. Scientific, quality and regulatory questions are referred to qualified specialists as appropriate. Market entry and permitted communication depend on the product and country.
Yes. Begin with a non-confidential overview, and we can discuss an NDA and the appropriate next steps before you share sensitive material.